Consolidated Statements of Changes in Stockholders' Equity (USD $)	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 1999	Mar. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007	Dec. 31, 2006	Dec. 31, 2005	Dec. 31, 2004	Dec. 31, 2003	Dec. 31, 2002	Dec. 31, 2001	Dec. 31, 2000
Issuance of initial shares	$ 20,873
Issuance of shares of common stock in exchange for services	36,960
Issuance of shares of common stock	62,700								105,000	958,481	1,409,621	690,600	77,941	926,500
Issuance of shares of common stock and stock options for acquisition of subsidiary													738,000
Stock issuance costs	(13,690)		(40,000)							(25,000)	(49,735)			(16,335)
Issuance of stock options													15,000
Exercise of warrants								55,500
Exercise of options			10,000					430					232,059
Beneficial conversion feature (see Note 3)						375,000
Fair value of non-employee stock options grants														50,350
Fair value of non-employee stock options			48,374	364	1,524	28,752	47,692	215,463	286,762	493,600	213,300	94,000	323,250
Fair value of employee stock options			47,658			19,720	67,651	135,098
Fair value of warrants issued for deferred finance charges								392,376
Fair value of warrants in conjunction with debt financing			21,275	20,143	15,450	25,000
Amortization of deferred consulting fees													20,683	20,117
Salary due to shareholder contributed capital												15,000
Return of shares of common stock related to purchase price adjustment												(354,000)
Shares retired upon cancellation of consulting agreements								(120)
Issuance of shares for services			30,000	208,600	47,700			55,000			24,000
Shares issued for conversion of notes payable and accrued interest					312,041
Purchase of common stock for treasury			(17,795)
Sale of common stock			400,000
Net loss	(54,113)	(235,605)	(665,113)	(721,841)	(694,910)	(931,338)	(1,117,334)	(1,607,017)	(1,266,811)	(1,406,506)	(1,107,120)	(1,195,753)	(1,052,299)	(367,829)
Balance at end of period, amount	52,730	(3,544,656)	(3,309,051)	(3,143,450)	(2,650,716)	(2,332,521)	(1,474,655)	(847,664)	(94,394)	780,655	760,080	270,014	1,020,167	665,533
Common Stock, Shares
Issuance of initial shares	4,278,000
Issuance of shares of common stock in exchange for services	1,232,000
Issuance of shares of common stock	2,090,000								3,000,000	18,600,000	22,512,764	3,376,875	217,500	5,449,999
Issuance of shares of common stock and stock options for acquisition of subsidiary													2,000,000
Exercise of warrants								5,550,000
Exercise of options			1,000,000					4,300,000					1,450,368
Balance at beginning of period, as restated, shares						73,440,506
Return of shares of common stock related to purchase price adjustment												(1,000,000)
Shares retired upon cancellation of consulting agreements								(1,200,000)
Issuance of shares for services			1,000,000	25,950,000	7,200,000			1,200,000			143,000			240,000
Shares issued for conversion of notes payable and accrued interest					48,750,000
Contribution of common stock from related parties			(12,000,000)
Purchase of common stock for treasury			(17,795,903)
Sale of common stock			15,500,000
Issuance of shares for stock issuance costs			2,100,000
Balance at end of period, shares	7,600,000	145,144,603	145,144,603	155,340,506	129,390,506	73,440,506	73,440,506	73,440,506	63,590,506	60,590,506	41,990,506	19,334,742	16,957,867	13,289,999
Common Stock, Amount
Issuance of initial shares	4,278
Issuance of shares of common stock in exchange for services	1,232
Issuance of shares of common stock	2,090								3,000	18,600	22,512	3,377	218	5,450
Issuance of shares of common stock and stock options for acquisition of subsidiary													2,000
Exercise of warrants								5,550
Exercise of options			1,000					4,300					1,450
Return of shares of common stock related to purchase price adjustment												(1,000)
Shares retired upon cancellation of consulting agreements								(1,200)
Issuance of shares for services			1,000	25,950	7,200			1,200			143			240
Shares issued for conversion of notes payable and accrued interest					48,750
Sale of common stock			15,500
Issuance of shares for stock issuance costs			2,100
Balance at end of period, amount	7,600	174,940	174,940	155,340	129,390	73,440	73,440	73,440	63,590	60,590	41,990	19,335	16,958	13,290
Treasury Stock
Contribution of common stock from related parties			(95,594)
Purchase of common stock for treasury			(17,795)
Balance at end of period, amount		(113,389)	(113,389)
Consulting Fee
Amortization of deferred consulting fees													20,683	20,117
Issuance of shares for services														(40,800)
Balance at end of period, amount														(20,683)
Additional Paid-In Capital
Issuance of initial shares	16,595
Issuance of shares of common stock in exchange for services	35,728
Issuance of shares of common stock	60,610								102,000	939,881	1,387,109	687,223	77,723	921,050
Issuance of shares of common stock and stock options for acquisition of subsidiary													736,000
Stock issuance costs	(13,690)		(40,000)							(25,000)	(49,735)			(16,335)
Issuance of stock options													15,000
Exercise of warrants								49,950
Exercise of options			9,000					(3,870)					230,609
Beneficial conversion feature (see Note 3)						375,000
Fair value of non-employee stock options grants														50,350
Fair value of non-employee stock options			48,374	364	1,524	28,752	47,692	215,463	286,762	493,600	213,300	94,000	323,250
Fair value of employee stock options			47,658			19,720	67,651	135,098
Fair value of warrants issued for deferred finance charges								392,376
Fair value of warrants in conjunction with debt financing			21,275	20,143	15,450	25,000
Salary due to shareholder contributed capital												15,000
Return of shares of common stock related to purchase price adjustment												(353,000)
Shares retired upon cancellation of consulting agreements								1,080
Issuance of shares for services			29,000	182,650	40,500			53,800			23,857			40,560
Shares issued for conversion of notes payable and accrued interest					263,291
Contribution of common stock from related parties			95,594
Sale of common stock			384,500
Issuance of shares for stock issuance costs			(2,100)
Balance at end of period, amount	99,243	8,817,382	8,817,382	8,224,081	8,020,924	7,700,159	7,626,687	7,136,344	6,292,447	5,903,685	4,495,204	2,920,673	2,477,450	1,094,868
Deficit Accumulated During the Development Stage
Net loss	(54,113)	(235,605)	(665,113)	(721,841)	(694,910)	(931,338)	(1,117,334)	(1,607,017)	(1,266,811)	(1,406,506)	(1,107,120)	(1,195,753)	(1,052,299)	(367,829)
Balance at end of period, amount	$ (54,113)	$ (12,423,589)	$ (12,187,984)	$ (11,522,871)	$ (10,801,030)	$ (10,106,120)	$ (9,174,782)	$ (8,057,448)	$ (6,450,431)	$ (5,183,620)	$ (3,777,114)	$ (2,669,994)	$ (1,474,241)	$ (421,942)